Novo Nordisk falls 4% after analyst downgrades

Tuesday, Feb 24, 2026 3:01 am ET1min read
NVO--

Novo Nordisk falls 4% after analyst downgrades

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet